What’s happening at Adaptive Biotechnologies Corporation (NasdaqGS:ADPT)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 5.45% (or 1.60 points) to $30.95 from its previous close of $29.35. So is it the right moment to buy?
The shares had a decreased trading volume of 485,666 contracts this session compared to the average daily volume of last 10 days of 732,362 contracts and they had a decreased trading volume compared to the average daily volume of last 3 months of 581,871 contracts.
The indicator of a company’s profitability, the earnings per share ratio is -1.51. This value shows how much money a company makes for each share of its stock. A higher EPS indicates more value because investors will pay more for a company with higher profits. This is negative and tells you exactly how much money the company lost per share of its 124.3M outstanding stock.
The closing market price for this trading session was 28.69% over 52 weeks minimum price of $24.05 and 43.85% under 52 weeks maximum price of $55.12. Also the price is -12.11% less than 200 day average of $35.21 and 8.62% greater than 50 day average of $28.49.
Latest news that might have contributed to the great perfomance of ADPT today are:
- Chad Robins led Adaptive Biotechnologies through a huge 2019, published on Tue, 17 Dec 2019 02:24:39 +0000
- Adaptive Biotechnologies Shares March Higher, Can It Continue?, published on Fri, 13 Dec 2019 09:52:09 +0000
- Fiverr Languishes Below IPO Price as First Chance to Sell Nears, published on Mon, 09 Dec 2019 13:44:30 +0000